5AM Partners VII, LLC sold SKYE
August 20, 2026 · Form 4 insider transaction
5AM Partners VII, LLC sold 6,495 shares of Skye Bioscience, Inc. at $0.32 per share, a transaction worth $2.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
The securities are directly held by 5AM Ventures VII, L.P. ("Ventures VII"). 5AM Partners VII, LLC ("Partners VII") is the sole general partner of Ventures VII. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VII and may be deemed to have shared voting and investment power over the securities beneficially owned by Ventures VII. Each of Partners VII and Dr. Parmar disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports.